Slides from a recent presentation by Prof Morten, the second half is mostly about this work. Near the end there is a slide about their next step...
I think the fact that they are looking at an objective outcome (ATG-13 in serum) makes it different, especially if they can correlate ATG-13 with...
I imagine Simmaron simply does not have the resources to do a full trial with a control group (their annual revenue is about half a million...
That's definitely not what the paper says though. Seems like Dr. Kaplan misread the paper, to start with. In it, they report 21 patients reported...
That was in a question to Nath, maybe it was just confusion on the part of the asker.
Just going off the content of these tweets, I think the idea is that there is antigen (could be persistent antigen from past infection or could be...
Isn't it interesting that out of their 25 healthy controls, only after the third round of screening did they discover that one had MS, one had...
This part of their exploratory outcomes seems interesting: "Cross-referencing heart rate patterns with participant-provided symptoms and...
FWIW, Nath's hypothesis seems to be: "(Our) hypothesis of persistent antigen as (cause of ME) is based on immune markers. That made us wonder if...
Hilary Johnson is tweeting notes from some of the sessions (Nath and Hanson): [MEDIA] Nath: (Conclusion) we think all our findings suggest...
Amazingly, all that machine learning and all those Network Medicine models came up with LDN and Mestinon, which were surely invisible to...
I think the weight for ME just doesn't exist officially in the WHO list. This Danish study, based on a questionnaire, came up with 0.47, while...
This thread has me thinking that I need to introduce some blinding into my own trials of medications. I think this would not do much for some...
The number of patients and controls is so small that it is hard to make much of this, but given the pretty significant difference seen here (which...
I love this: No change in the objective symptoms, but since the patients could now complete the test, they must be improved.
Some interesting points made about one of the author on Twitter, seems reasonable to me to assume there could be some level of (undisclosed) AI...
He, unfortunately given his huge audience, so consistently posts incorrect summaries of papers he clearly hasn't read on Twitter, that it's hard...
OMF posted an update on the Kynurenine trial at some point: IRB approval has been obtained and trial conducted in healthy volunteers. Paper...
I'm searching for pulmonary vascular capacitance and finding that it seems to be defined as stroke volume divided by pulse pressure, but here they...
"the treatment group (n=37, dose range: 24-360mg/d) demonstrated a significant increase in oxygen uptake efficiency slope (OUES) (T0: 1.82 ± 0.56,...
Separate names with a comma.
